141 related articles for article (PubMed ID: 19101839)
1. Lipolytic activity of chromoblastomycosis agents measured by infrared spectroscopy and chemometric methods.
Corbellini VA; Scroferneker ML; Carissimi M; da Costa JM; Ferrão MF
Med Mycol; 2009 Feb; 47(1):63-9. PubMed ID: 19101839
[TBL] [Abstract][Full Text] [Related]
2. Secretion of five extracellular enzymes by strains of chromoblastomycosis agents.
Souza TF; Scroferneker ML; Costa JM; Carissimi M; Corbellini VA
Rev Inst Med Trop Sao Paulo; 2008; 50(5):269-72. PubMed ID: 18949343
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
Iwatsu T; Miyaji M; Taguchi H; Okamoto S
Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis.
Hayakawa M; Ghosn EE; da Gloria Teixeria de Sousa M; Ferreira KS; Almeida SR
Scand J Immunol; 2006 Oct; 64(4):382-7. PubMed ID: 16970678
[TBL] [Abstract][Full Text] [Related]
5. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B.
Daboit TC; Massotti Magagnin C; Heidrich D; Czekster Antochevis L; Vigolo S; Collares Meirelles L; Alves K; Scroferneker ML
Mycoses; 2014 Feb; 57(2):116-20. PubMed ID: 23895037
[TBL] [Abstract][Full Text] [Related]
7. Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis.
Abliz P; Fukushima K; Takizawa K; Nishimura K
J Clin Microbiol; 2004 Jan; 42(1):404-7. PubMed ID: 14715791
[TBL] [Abstract][Full Text] [Related]
8. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Yu J; Li R; Zhang M; Liu L; Wan Z
Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
[TBL] [Abstract][Full Text] [Related]
9. Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi using Fourier Transform Infrared Spectroscopy (FTIR) and chemometrics.
Koehler A; Corbellini VA; Heidrich D; Scroferneker ML
PLoS One; 2020; 15(12):e0243231. PubMed ID: 33264365
[TBL] [Abstract][Full Text] [Related]
10. Chromoblastomycosis.
Milam CP; Fenske NA
Dermatol Clin; 1989 Apr; 7(2):219-25. PubMed ID: 2670367
[TBL] [Abstract][Full Text] [Related]
11. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
12. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
Khan S; Kumar A; Vinod V; Prabhakar V; Eapen M; Thomas J; Dinesh K; Karim S
J Infect Dev Ctries; 2015 Mar; 9(3):325-9. PubMed ID: 25771474
[TBL] [Abstract][Full Text] [Related]
13. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.
Najafzadeh MJ; Sun J; Vicente V; Xi L; van den Ende AH; de Hoog GS
Med Mycol; 2010 Sep; 48(6):800-6. PubMed ID: 20302550
[TBL] [Abstract][Full Text] [Related]
14. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):21-9. PubMed ID: 16420593
[TBL] [Abstract][Full Text] [Related]
15. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
Park SG; Oh SH; Suh SB; Lee KH; Chung KY
Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
[TBL] [Abstract][Full Text] [Related]
16. Lipases of Fonsecaea pedrosoi and Phialophora verrucosa.
Okeke CN; Gugnani HC
Antonie Van Leeuwenhoek; 1989 Apr; 55(4):313-24. PubMed ID: 2729958
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Mycopathologia; 2010 Jul; 170(1):31-7. PubMed ID: 20195904
[TBL] [Abstract][Full Text] [Related]
18. Prediction of melanin content of Fonsecaea pedrosoi using Fourier transform infrared spectroscopy (FTIR) and chemometrics.
Koehler A; de Moraes PC; Heidrich D; Scroferneker ML; Ferrão MF; Corbellini VA
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 310():123945. PubMed ID: 38295590
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.
Montoya AM; Montesino CA; Carrión-Álvarez D; González GM; Rojas OC
Microb Pathog; 2020 Oct; 147():104367. PubMed ID: 32649963
[TBL] [Abstract][Full Text] [Related]
20. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea.
Lim SW; Suh MK; Kang GS; Ha GY; Kim H; Choi JS; Kim YS
Mycoses; 2011 Sep; 54(5):e415-20. PubMed ID: 21910758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
